T Cell News and Research

Latest T Cell News and Research

New compound appears to prevent pain crises in sickle cell disease: GHSU

A new compound appears to prevent the traffic jam of cells that causes debilitating pain crises and associated mortality in sickle cell disease, Georgia Health Sciences University researchers report.

1 Feb 2011

Fluidigm launches new BioMark HD Real-time PCR System for genomic analysis

Fluidigm today introduced the new BioMark HD Real-time PCR System, the company's most advanced instrument for genomic analysis ever. The BioMark HD System is designed for researchers who require the sensitivity and throughput needed to study gene expression down to the single-cell level -- especially those who have limited amounts of sample or study rare populations of cells.

1 Feb 2011

FDA, Optivia collaborate to examine effect of dietary supplements in drug-induced liver injury

Optivia Biotechnology, a leading provider of in vitro transporter assay services, today announced that the company and the U.S. Food and Drug Administration have signed a collaboration agreement to assess the effect of dietary supplements on key drug transporters.

1 Feb 2011

DRC processors running Smith-Waterman algorithm set new world record

DRC Computer Corporation (DRC), the leading innovator of dynamically reconfigurable processors, announces that it has achieved 9.4 trillion cell updates per second (TCUPS) running the Smith-Waterman algorithm with Affine gap model on the latest DRC Accelium coprocessors.

1 Feb 2011

AVEO commences enrollment in tivozanib Phase 2 study in renal cell carcinoma

AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).

1 Feb 2011

Circassia Phase II clinical trial confirms safety profile of ToleroMune cat allergy treatment

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.

1 Feb 2011

Extensive, reversible changes in heart take place when exposed to low oxygen levels

From the highest mountaintop comes a new research report in the FASEB Journal that gets to the bottom of what happens to the hearts of people when exposed to low-levels of oxygen, such as those on Mount Everest or in the intensive care unit of a hospital.

1 Feb 2011

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

1 Feb 2011

Researchers grow arteries with elasticity of natural blood vessels outside the body

University of Pittsburgh researchers have grown arteries that exhibit the elasticity of natural blood vessels at the highest levels reported, a development that could overcome a major barrier to creating living-tissue replacements for damaged arteries, the team reports in the Proceedings of the National Academy of Sciences.

1 Feb 2011

Agilent Technologies launches AssayMAP Bravo for protein purification

Agilent Technologies today announced the launch of the AssayMAP Bravo platform and protein purification cartridges, a fully automated solution for high-throughput protein sample preparation and purification.

1 Feb 2011

Agilent adds BenchBot Robot to line of automated microplate handling equipment

Agilent Technologies Inc. announced today the addition of the BenchBot Robot to its line of automated microplate handling equipment. As part of Agilent's Automation Solutions instrumentation portfolio, the BenchBot complements the Direct Drive Robot and BenchCel Microplate Handler.

1 Feb 2011

ISCO, Springer to collaborate to publish Cellular Oncology journal

Springer and the International Society of Cellular Oncology will collaborate to publish Cellular Oncology starting this year. Cellular Oncology is the official journal of ISCO and publishes original papers and reviews on the latest advances in cancer research. It was previously published by IOS Press.

1 Feb 2011

FDA approves 'Cornell Dots' for first clinical trial in humans to diagnose cancer

"Cornell Dots" - brightly glowing nanoparticles - may soon be used to light up cancer cells to aid in diagnosing and treating cancer. The U.S. Food and Drug Administration has approved the first clinical trial in humans of the new technology.

1 Feb 2011

Novel personalized therapy could treat metastatic melanoma and metastatic synovial cell sarcoma

Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.

1 Feb 2011

Widespread screening or ultrasound for blocked neck arteries not necessary to determine stroke risk

Widespread screening or routine ultrasound for blocked neck arteries to determine stroke risk isn't necessary, according to new guidelines from the American Heart Association/American Stroke Association, American College of Cardiology and other groups.

1 Feb 2011

Free radicals may damage eyes of patients with Fuchs Endothelial Corneal Dystrophy

Scientists have found that free radicals (unstable molecules that cause the death of cells as the body ages) may also cause the damage in the eyes of patients with Fuchs Endothelial Corneal Dystrophy (FECD), a hereditary disease that is one of the most common reasons for corneal transplants worldwide.

1 Feb 2011

Scientists devise safer way to create iPS cells

Researchers at Johns Hopkins have found a better way to create induced pluripotent stem (iPS) cells-adult cells reprogrammed with the properties of embryonic stem cells-from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.

1 Feb 2011

Simple hTERT analysis may provide useful prognostic tool in advanced non-small cell lung cancer

High levels of circulating DNA may indicate faster progression of lung cancer and lower overall survival, according to a study published in the February edition of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC).

1 Feb 2011

Study finds E2F5 transcription factor commonly overexpressed in primary human HCC

E2F5 is a member of the E2F transcription factor family, and plays a key role in cell growth and proliferation. Overexpression of E2F5 has been reported in various human cancers, but not in liver cancer, and its biological implication is largely unknown. It is not known whether E2F5 plays a tumor suppressor role or an oncogenic role.

1 Feb 2011

IASLC publishes new international multidisciplinary classification for lung adenocarcinoma

Three of the world's top lung associations have published a new international multidisciplinary classification of lung adenocarcinoma, the first revision to the classification in six years.

1 Feb 2011

T Cell News and Research

Latest T Cell News and Research

New compound appears to prevent pain crises in sickle cell disease: GHSU

Fluidigm launches new BioMark HD Real-time PCR System for genomic analysis

FDA, Optivia collaborate to examine effect of dietary supplements in drug-induced liver injury

DRC processors running Smith-Waterman algorithm set new world record

AVEO commences enrollment in tivozanib Phase 2 study in renal cell carcinoma

Circassia Phase II clinical trial confirms safety profile of ToleroMune cat allergy treatment

Extensive, reversible changes in heart take place when exposed to low oxygen levels

Octreotide inhibits HepG2 proliferation, study confirms

Researchers grow arteries with elasticity of natural blood vessels outside the body

Agilent Technologies launches AssayMAP Bravo for protein purification

Agilent adds BenchBot Robot to line of automated microplate handling equipment

ISCO, Springer to collaborate to publish Cellular Oncology journal

FDA approves 'Cornell Dots' for first clinical trial in humans to diagnose cancer

Novel personalized therapy could treat metastatic melanoma and metastatic synovial cell sarcoma

Widespread screening or ultrasound for blocked neck arteries not necessary to determine stroke risk

Free radicals may damage eyes of patients with Fuchs Endothelial Corneal Dystrophy

Scientists devise safer way to create iPS cells

Simple hTERT analysis may provide useful prognostic tool in advanced non-small cell lung cancer

Study finds E2F5 transcription factor commonly overexpressed in primary human HCC

IASLC publishes new international multidisciplinary classification for lung adenocarcinoma

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in